Magazine Editorials

 

Clinical courses

 

Clinical courses

  • 6 October 2017

    HOW DIGITALIZATION CAN BE UTILIZED FOR BETTER MARKETING & SALES IN PHARMACEUTICALS

    ABOUT AUTHOR
    Rajesh Vagh
    PharmaTutor Edu Labs
    Surat, Gujarat, India

    So far, medical representatives are assets for pharma sales but need of time and competitions are asking for variant ways to promote their products. Patient portals, apps and online communities should be developed with more intensity and utilize technologies to improve customer experience.

  • 3 August 2017
    MONOCLONAL ANTIBODIES – RISE OF NEW BUSINESS FRONTIERS

    ABOUT AUTHOR
    Rajesh S Vagh
    PharmaTutor Edu Labs,
    Surat, Gujarat, India
    rajesh@pharmatutor.org

    Monoclonal antibodies (mAbs) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have amonovalent affinity, in that they bind to the same epitope.

  • 5 July 2017
    Nobel to Artimsisinin discoverer will surely encourage research in natural products

    Amit Gangwal
    MPharm., PhD.,
    gangwal.amit@gmail.com

    This has been made possible by years of honest research in Ayurvedic formulae and therefore people are getting results. This is not a small success, looking at the no of years, Patanjali has been in market and it’s whopping turnover.

    The Nobel Prize in Physiology or Medicine has been awarded 106 times to 210 Nobel Laureates between 1901 and 2015, as per the information depicted on nobelprize.org/nobel_prizes/medicine/ laureates/. It further reads-The Nobel Prize in Physiology or Medicine 2015 was divided, one half jointly to William C. Campbell and Satoshi Ōmura "for their discoveries concerning a novel therapy against infections caused by roundworm parasites" and the other half to Youyou Tu "for her discoveries concerning a novel therapy against Malaria".

  • 29 April 2017
    Generic drug prescription: Possible issues, impacts and consequences

    { DOWNLOAD AS PDF }

    ABOUT AUTHOR
    Shashank Chaturvedi
    Department of Pharmaceutics
    Invertis Institute of Pharmacy,
    Invertis University, Bareilly, U.P
    shashank.c@invertis.org

    ABSTRACT
    The generic drug and branded drug is a confusing concept, and is a matter of serious concern for the pharmaceutical sector after the imposition of the rule that every physician should prescribe drugs with generic names legibly and preferably in capital letters and he/she shall ensure that there is a rational prescription and use of drugs. The generic drug should be bioequivalent before they can be prescribed as an alternative from their branded counterparts. The possible impacts over the Pharmaceutical Sector should be assessed before implementing this mammoth decision.

    (adsbygoogle = window.adsbygoogle || []).push({});

  • After the demonetisation of 500 and 1000 rupees notes, numerous sectors are being affected and hopefully we all have been affected with that. Also Global banks and rating agencies have downgraded India’s growth in the wake of demonetisation of high level. Current year’s GDP rate has been slowed down to 6.5. But Pharmaceutical industries are growing with good margin. Even shares of pharmaceutical industries are rating higher.

  • 4 August 2015
    Onion, Garlic & Ginger hold promise for future medication

    Editorial, July 2015 issue

    “ We all know about onion, garlic and ginger. People are using them as food, salad, spice, or condiments (I put their use together). Many recipes are tasteless and considered to be incomplete without their use (onion, garlic and ginger) in dishes. There are various uses or documented uses (in various ailments) of these three natural stuff, uprooted from ground, when matured. The trio is underground modification of stem. Onion and garlic are bulbs and ginger is an example of rhizome, from view point of botany. Will it be wrong to compare these three with Vicks, Iodex and Zandu Balm, from view point of utility and importance and indispensability?

  • 11 June 2015
    Budding entrepreneurs make most of this time: Consumers are taking novel ideas and comfort providing solutions hand to hand

    Editorial, May 2015 issue

  • 2 April 2015
    Improvement in drug manufacturing standards: an initiative of government of India

    Editorial, Mar 2015 issue

    “ Globalization of the pharmaceutical industry has the potential to rapidly spread poor-quality medicines worldwide. This is due to lack of expertise, poor manufacturing practices. It influence public

  • 13 March 2015
    Drug price control: Should be win-win situation for Patients and Industries

    Editorial, Feb 2015 issue

    “ Getting access for patented formulation or molecule by poor patients is a bigger healthcare challenge. As we are aware that developing a new molecule cost in billions to pharmaceutical companies and it takes at least 12 years to reach the milestone.

Subscribe to Magazine Editorials

Subscribe with us




 


 

 

Do Not Forget to Verify

(Click on Subscription link in your inbox)

--------

whatsapp

 

Also Join:  youtube  telegram

admission for pharma MBA

 

GPAT

Jobs by Category

Production Jobs

R&D Jobs

F&D Jobs

Sales & Marketing

QA Jobs

QC Jobs

Faculty Jobs

CRO Jobs

DRA Jobs

IPR Jobs

IT Jobs

Packaging Alerts

Hospital Pharmacist